H.R. 4762: Medical Supply Sanctions Act of 2025
This bill, known as the Medical Supply Sanctions Act of 2025, aims to impose restrictions on the export of certain medical supplies to the Russian Federation. Below is a summary of the main provisions of the bill:
Short Title
The bill is referred to as the Medical Supply Sanctions Act of 2025.
Prohibition on Export
The bill establishes a requirement for the President to prohibit the export of drugs and prosthetics to the Russian Federation. This prohibition is intended to remain in effect regardless of any other laws that may conflict with this action.
Definitions
To clarify the terms used in the bill:
- Drug: According to the bill, a drug is defined as any medication that has received approval from the relevant health authorities, specifically the Federal Food, Drug, and Cosmetic Act, and may include its components.
- Prosthetic: A prosthetic is defined as a medical device that replaces or improves the function of a body part and must be approved for marketing by the Food and Drug Administration. This includes any parts or accessories associated with the prosthetic.
Termination of Prohibition
The prohibition on exporting these medical supplies will remain in effect until the Secretary of State certifies to Congress that the Russian Federation has:
- Ceased military operations in Ukraine
- Removed its military forces from Ukraine
Overall Intent
The primary goal of this legislation is to restrict access to critical medical supplies in response to ongoing military actions by Russia, specifically its operations in Ukraine. The bill reflects a broader legislative effort to use economic measures as a tool in foreign policy.
Relevant Companies
- None found
This is an AI-generated summary of the bill text. There may be mistakes.
Sponsors
1 sponsor
Actions
2 actions
| Date | Action |
|---|---|
| Jul. 25, 2025 | Introduced in House |
| Jul. 25, 2025 | Referred to the House Committee on Foreign Affairs. |
Corporate Lobbying
0 companies lobbying
None found.
* Note that there can be significant delays in lobbying disclosures, and our data may be incomplete.
Potentially Relevant Congressional Stock Trades
No relevant congressional stock trades found.